Loading company…
Riskpilot
← Back to search
Sign in
Get full access
TRYGG PHARMA GROUP AS
AS
Active
Org 994555405
Oksenøyveien 10, 1366 Lysaker
Produksjon av rå fiskeoljer og fett · NACE 10411
Est. 2009
0 employees
www.tryggpharma.com
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2020
NOK 0
EBITDA margin
—
-44% vs 2019
Equity ratio
96.0%
Financial strength
Net profit 2020
NOK 1,2M
-88% vs 2019
EBITDA — year on year
NOK millions
4M
-13M
-29M
-45M
-61M
-20M
2016
-49M
-145%
2017
3M
+106%
2018
0M
-100%
2019
0M
0%
2020
Key figures
Annual report 2020
Revenue
NOK 0
—
EBITDA
NOK -130K
-44%
Net profit
NOK 1,2M
-88%
Total assets
NOK 32,5M
+4%
Equity
NOK 31,2M
+4%
Employees
0
—
Company information
Legal name
TRYGG PHARMA GROUP AS
Org number
994555405
Legal form
Aksjeselskap
NACE code
10411 · Produksjon av rå fiskeoljer og fett
Founded
30. september 2009
Share capital
NOK 59 708 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Utvikle, rettighetsbeskyttelse, produsere og selge omega 3 konsentrater for kosttilskudd, matvareingrediens, farmasi og pet food.
Contact
Address
Oksenøyveien 10, 1366 Lysaker
Website
www.tryggpharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Produksjon av rå fiskeoljer og fett
Companies in Bærum
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
0M
2020
EBITDA
NOK millions
0M
1M
2M
3M
3M
-20M
2016
-49M
2017
3M
2018
0M
2019
0M
2020
Income statement
NOK thousands
Item
2016
2017
2018
2019
2020
Revenue
0
0
0
0
0
Staff expenses
−821
−315
−8
−0
−0
EBITDA
−19 807
−48 707
2 590
−90
−130
Depreciation & amort.
−12 000
−0
−0
−0
−0
EBIT
−31 807
−48 707
2 590
−90
−130
Net financials
−3 633
−1 097
−423
10 836
1 374
Profit before tax
−35 440
−49 804
2 167
10 746
1 244
Tax
−0
−0
−0
−0
−0
Net profit
−35 440
−49 804
2 167
10 746
1 244
Balance sheet
NOK thousands
Item
2016
2017
2018
2019
2020
Total assets
86 651
33 979
21 069
31 220
32 475
Equity
66 825
17 021
19 188
29 933
31 177
Long-term debt
0
0
0
0
0
Short-term debt
19 826
16 959
1 882
1 287
1 298
Total debt
19 826
16 959
1 882
1 287
1 298
Financial ratios
5-year trend
EBITDA margin
-13000000.0%
This company
15.8%
Market median
-82278581% vs market
2016
2020
Equity ratio
96.0%
This company
38.2%
Market median
+151% vs market
2016
2020
Return on equity
4.0%
This company
18.4%
Market median
-78% vs market
2016
2020
Net profit margin
124400000.0%
This company
8.1%
Market median
+1535802369% vs market
2016
2020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2016
2020
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
2016
2020
Annual reports & filings
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
OS
Ola Snøve
Chairman
2018
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of TRYGG PHARMA GROUP AS also hold positions in
0
other companies.
Person
Role here
Other companies
Ola Snøve
Chairman
0 companies